• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Global pharmaceutical survey 2013 2014 - market trends, buyer spend and procurement strategies in the global pharmaceutical industry
 

Global pharmaceutical survey 2013 2014 - market trends, buyer spend and procurement strategies in the global pharmaceutical industry

on

  • 442 views

 

Statistics

Views

Total Views
442
Views on SlideShare
442
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Global pharmaceutical survey 2013 2014 - market trends, buyer spend and procurement strategies in the global pharmaceutical industry Global pharmaceutical survey 2013 2014 - market trends, buyer spend and procurement strategies in the global pharmaceutical industry Document Transcript

    • www.reportscorner.comReports Corner has added “Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spendand Procurement Strategies in the Global Pharmaceutical Industry” to its latest reports offering.Please visit the link (https://www.reportscorner.com/report_detail.php?r_id=9823 )Product Synopsis“Global Pharmaceutical Survey 2013-2014: Market Trends, Buyer Spend and Procurement Strategiesin the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes howpharmaceutical industry companies procurement expenditures, business strategies, and practicesare set to change in 2013-2014. Additionally, this report also presents comparative analysisbetween four years of survey results (wherever applicable). This report gives access to category-level spending outlooks, budgets, supplier selection criteria, business challenges, and investmentopportunities of leading purchase decision makers. The report also identifies the future growth ofbuyers and suppliers, MandA, capital expenditure, staff hiring, and e-procurement. This report notonly grants access to the opinions and strategies of business decision makers and competitors, butalso examines their actions surrounding business priorities, as well as access to informationcategorized by region, company type, and size.Introduction and LandscapeWhy was the report written?This report is the result of an extensive survey drawn from ICD Researchs exclusive panel of leadingglobal pharmaceutical industry executives; it provides data and analysis on buyer expenditure,procurement, and developments within the global pharmaceutical industry. The report includes keytopics such as global pharmaceutical industry buyer expenditure and procurement behaviours andstrategies, and identifies the threats and opportunities within the global pharmaceutical industry,economic outlook trends, and business confidence within global pharmaceutical executives. Mostsecondary research reports are based on general industry drivers and do not understand theindustry executives attitude and changing behaviours, creating a gap in presenting the businessoutlook of the industry; in an effort to bridge this gap, ICD Research created this primary-researchbased report by gathering the opinions of multiple stakeholders in the value-chain of the globalpharmaceutical industry.What is the current market landscape and what is changing?Executives from the global pharmaceutical industry anticipate an increase in levels ofconsolidation, with 61% of respondents projecting an increase in MandA activities in 2013.What are the key drivers behind recent market changes?The need for new product pipelines, new product acquisition, patent expiries, cost containmentand credit availability have prompted companies to consolidate positions and look for merger andMandA acquisition.What makes this report unique and essential to read?This report is the result of an extensive survey drawn from ICD Researchs exclusive panel of leadingglobal pharmaceutical industry executives; it provides data and analysis on buyer expenditure,
    • procurement, and developments within the global pharmaceutical industry. The report includes keytopics such as global pharmaceutical industry buyer expenditure and procurement behaviours andstrategies, and identifies the threats and opportunities within the global pharmaceutical industry,economic outlook trends, and business confidence within global pharmaceutical industryexecutives. Additionally, this report also presents comparative analysis between four years ofsurvey results (wherever applicable).Key Features and BenefitsProject industry trends and revenue growth expectations in 2013, and understand businessconfidence to make informed business decisions.Drive revenues by understanding future product investment areas and key growth regions.Uncover key challenges and opportunities, and identify the key actions required to maintain andwin buyer business.Formulate effective sales and marketing strategies by identifying how buyer budgets are changingand the direction of spending in the future. Better promote your business by aligning yourcapabilities and business practices with your customers changing needsSecure stronger customer relationships by understanding the behaviour and changing strategies ofindustry buyers.Key Market IssuesChina, Brazil and India are the important emerging markets to offer growth in 2013.Market uncertainty, responding to price pressure, rising competition and regulatory changes arethe leading business concerns for the global pharmaceutical industry in 2013.Overall, for 2013, the average size of the annual procurement budget for global pharmaceuticalindustry buyer respondents is projected at US$127 million, against US$127 million in 2012 andUS$110 million in 2011.Price, level of service and existing relationship with supplier are considered the most importantfactors for supplier selection in the global pharmaceutical industry, while environmental recordsand CSR, brand reputation and proximity of supplier operations are considered the leastimportant.While 16% of buyer respondents from the global pharmaceutical industry are willing to implemente-procurement in 2013 or beyond, 32% are already in the different stages of implementation(partially implemented, completely implemented, and evaluation or pilot use)Key HighlightsAn analysis of revenue growth expectations by senior level respondents reveals that 62% are moreoptimistic about their companys revenue growth in 2013.A significant percentage of pharmaceutical manufacturing industry respondents highlighted thatcapital expenditure towards new product development, employee training, and IT infrastructuredevelopment would increase in 2013.The top three priorities for global pharmaceutical industry buyer respondents in 2013 are newproducts and services, improve operational efficiency and expand in current markets.
    • A total of 49% of respondents from pharmaceutical manufacturing companies, 68% of respondentsfrom CROs and CMOs companies, and 64% of respondents from pharmaceutical industry suppliercompanies anticipate an increase of their current workforce in 2013.Survey results show that respondents from the global pharmaceutical industry identified the US tooffer the highest growth potential among developed countries in 2013-2014.Table of Contents1 Introduction1.1 What is This Report About?1.2 Definitions1.3 Methodology1.4 Profile of Survey Respondents: Global Pharmaceutical Industry1.4.1 Global pharmaceutical industry: profile of buyer respondents1.4.2 Global pharmaceutical industry: profile of supplier respondents2 Executive Summary3 Global Pharmaceutical Industry Dynamics3.1 Revenue Growth Projections in the Global Pharmaceutical Industry3.1.1 Revenue growth projections by company type3.1.2 Revenue growth projections by region3.1.3 Revenue growth projections by company turnover3.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents3.2 Future Developments in Business Structure in the Global Pharmaceutical Industry3.2.1 Future developments in business structure by buyers3.2.2 Future developments in business structure by suppliers3.2.3 Future developments in business structure by region3.2.4 Future developments in business structure by company turnover3.2.5 Future developments in business structure by senior level respondents3.3 Change in Leading Company Strategies in the Global Pharmaceutical Industry3.3.1 Change in leading company strategies by buyers3.3.2 Change in leading company strategies by suppliers3.3.3 Change in leading company strategies by region3.3.4 Change in leading company strategies by company turnover3.4 Merger and Acquisition (MandA) Activity Projections in the Global Pharmaceutical Industry3.4.1 MandA activity projections by buyers3.4.2 MandA activity projections by suppliers3.4.3 MandA activity projections by region3.4.4 MandA activity projections by company turnover3.4.5 MandA activity projections by purchasing decision authority3.4.6 Global pharmaceutical industry - expand abroad Vs MandA activity projections3.5 Estimation of Capital Expenditure in the Global Pharmaceutical Industry3.5.1 Estimation of capital expenditure by buyers3.5.2 Estimation of capital expenditure by suppliers3.5.3 Estimation of capital expenditure by region3.5.4 Estimation of capital expenditure by company turnover3.6 Planned Change in Staff Recruitment Activity in the Global Pharmaceutical Industry3.6.1 Planned change in staff recruitment activity by buyers3.6.2 Planned change in staff recruitment activity by suppliers3.6.3 Planned change in staff recruitment activity by region3.6.4 Planned change in staff recruitment activity by company turnover
    • 4 Global Pharmaceutical Industry Market Growth Outlook4.1 Global Pharmaceutical Industry: Demand in Emerging Markets4.1.1 Demand in emerging markets by buyers4.1.2 Demand in emerging markets by suppliers4.1.3 Demand in emerging markets by region4.1.4 Demand in emerging markets by company turnover4.2 Global Pharmaceutical Industry - Growth Projections in Developed Countries4.2.1 Growth projections in developed countries by buyers4.2.2 Growth projections in developed countries by suppliers4.2.3 Growth projections in developed countries by region4.2.4 Growth projections in developed countries by company turnover5 Threats and Opportunities for the Global Pharmaceutical Industry5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2013-20145.1.1 Leading business concerns for 2013-2014 by company type5.1.2 Leading business concerns for 2013-2014 by region5.1.3 Leading business concerns for 2013-2014 by company turnover5.2 Global Pharmaceutical Industry: Key Supplier Actions to Maintain and Win Buyer Business5.2.1 Actions to maintain and secure buyer business by buyers5.2.2 Actions to maintain and secure buyer business by region5.2.3 Actions to maintain and secure buyer business by company turnover5.2.4 Actions to maintain and secure buyer business by purchasing decision authority6 Global Pharmaceutical Industry Buyer Expenditure Activity6.1 Annual Procurement Budgets in the Global Pharmaceutical Industry6.1.1 Revenue growth vs. procurement budget6.1.2 Annual procurement budgets by company type6.1.3 Annual procurement budgets by region6.1.4 Annual procurement budgets by company turnover6.1.5 Annual procurement budgets by senior level respondents6.2 Planned Change in Procurement Expenditure in the Global Pharmaceutical Industry6.2.1 Planned change in procurement expenditure by buyer type6.2.2 Planned change in procurement expenditure by region6.2.3 Planned change in procurement expenditure by company turnover6.2.4 Planned change in procurement expenditure vs. revenue growth optimism6.2.5 Planned change in procurement expenditure vs. cost containment6.3 Planned change in Procurement Expenditure by Product and Service Category6.3.1 Planned change in procurement expenditure by product and service category - region6.3.2 Planned change in procurement expenditure by product and service category - companyturnover6.4 Global Pharmaceutical Industry: Variations in Regional Supplier Prices6.4.1 Variations in regional supplier prices by company type6.4.2 Variations in regional supplier prices by region6.4.3 Variations in regional supplier prices by company turnover7 Global Pharmaceutical Industry: Procurement Behaviors and Strategies7.1 Global Pharmaceutical Industry: Critical Success Factors for Supplier Selection7.2 E-procurement in the Global Pharmaceutical Industry7.2.1 E-procurement in the global pharmaceutical industry by buyer type7.2.2 E-procurement in the global pharmaceutical industry by region7.2.3 E-procurement in the global pharmaceutical industry by company turnover8 Appendix8.1 Global Pharmaceutical Industry Survey Results- Closed Questions
    • 8.2 Methodology8.3 Contact us8.4 About ICD Research8.5 DisclaimerList of TablesTable 1: Global Pharmaceutical Industry Survey Respondents by Company Type, 2013Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2013Table 3: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2013Table 4: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2013Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2013Table 6: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2013Table 7: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2013Table 8: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013Table 9: Revenue Growth Optimism in the Global Pharmaceutical Industry by Buyers (%), 2010-2013Table 10: Revenue Growth Optimism in the Global Pharmaceutical Industry by Suppliers (%), 2010-2013Table 11: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%),2013Table 12: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013Table 13: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry(%), 2013Table 14: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry(%), 2013Table 15: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry(%), 2013Table 16: Key Expected Changes in Business Structure by Turnover - Global Pharmaceutical Industry(%), 2013Table 17: Key Expected Changes In Business Structure by Senior Level Respondents - GlobalPharmaceutical Industry (%), 2013Table 18: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%),2013Table 19: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%),2013Table 20: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%),2013Table 21: MandA Activity Projections - Global Pharmaceutical Manufacturers Industry (%), 2010-2013Table 22: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013Table 23: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013Table 24: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013Table 25: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013Table 26: Global Pharmaceutical Industry MandA Activity Projections by Purchasing DecisionAuthority (%), 2013Table 27: Global Pharmaceutical Industry - Expand Abroad vs. MandA Activity Projections(%), 2013Table 28: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013Table 29: Change in Capital Expenditure by Global CROs and CMOs (%), 2013Table 30: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013Table 31: Global Pharmaceutical Industry - Increase in Capital Expenditure by Region (%), 2013
    • Table 32: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%),2013Table 33: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity(%), 2013Table 34: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region(%), 2013Table 35: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity byTurnover (%), 2013Table 36: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013Table 37: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013Table 38: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013Table 39: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%),2013Table 40: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%),2013Table 41: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries(%), 2013Table 42: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countriesby Turnover (%), 2013Table 43: Global Pharmaceutical Industry - Leading Business Concerns (%), 2010-2013Table 44: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013Table 45: Global Pharmaceutical Industry - Leading Business Concerns by Region (%), 2013-2014Table 46: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses(%), 2013Table 47: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%),2013Table 48: Global Pharmaceutical Industry - Securing Buyer Business by Turnover (%), 2013Table 49: Securing Buyer Business in the Global Pharmaceutical Industry - by Purchasing DecisionAuthority (%), 2013Table 50: Annual Procurement Budgets of Global Pharmaceutical Industry Manufacturers in US$ (%),2010-2013Table 51: Global Pharmaceutical Industry Buyers - Increase in Revenue Growth vs. ProcurementBudget (%), 2013Table 52: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by BuyerType (%), 2013Table 53: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ byRegion(%), 2013Table 54: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Turnover(%), 2013Table 55: Global Pharmaceutical Industry - Annual Procurement Budgets in US$ by Senior LevelRespondents (%), 2013Table 56: Change in Procurement Expenditure - Global Pharmaceutical Industry Buyers (%), 2010-2013Table 57: Global Pharmaceutical Industry - Change in Procurement Expenditure by Buyer Type (%),2013Table 58: Global Pharmaceutical Industry - Change in Procurement Expenditure by Region (%), 2013Table 59: Global Pharmaceutical Industry - Change in Procurement Expenditure by Turnover (%),2013Table 60: Global Pharmaceutical Industry - Change in Procurement Expenditure vs. Revenue Growth(%), 2013
    • Table 61: Global Pharmaceutical Industry - Change in Procurement Expenditure vs. CostContainment (%), 2013Table 62: Future Change in Expenditure by Product and Service Category, Pharmaceutical IndustryManufacturers (%), 2013Table 63: Future Change in Expenditure by Product and Service Category, CROs and CMOs (%), 2013Table 64: Increase in Expenditure by Product and Service Category - Buyers by Region , 2013Table 65: Global Pharmaceutical Industry - Variations in Regional Supplier Prices (%), 2013Table 66: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Company Type(%), 2013Table 67: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Region (%),2013Table 68: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Turnover (%),2013Table 69: Critical Success Factors for Supplier Selection - Global Pharmaceutical Industry Buyers,2013Table 70: E-Procurement - Level of Implementation in the Global Pharmaceutical Industry (%), 2013Table 71: E-Procurement in the Global Pharmaceutical Industry: by Buyer Type(%), 2013Table 72: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2013Table 73: E-Procurement in the Global Pharmaceutical Industry by Turnover (%), 2013Table 74: Survey Results - Closed QuestionsList of FiguresFigure 1: Revenue Growth Optimism in the Global Pharmaceutical Industry (%), 2010-2013Figure 2: Revenue Growth Optimism in the Global Pharmaceutical Industry by Company Type (%),2010-2013Figure 3: Revenue Growth Optimism in the Global Pharmaceutical Industry by Region (%), 2013Figure 4: Revenue Growth Optimism in the Global Pharmaceutical Industry by Turnover (%), 2013Figure 5: Revenue Growth Optimism by Senior Level Respondents - Global Pharmaceutical Industry(%), 2013Figure 6: Key Expected Changes in Business Structure by Buyers - Global Pharmaceutical Industry(%), 2013Figure 7: Key Expected Changes in Business Structure by Suppliers - Global Pharmaceutical Industry(%), 2013Figure 8: Key Expected Changes in Business Structure by Region - Global Pharmaceutical Industry(%), 2013Figure 9: Change in Leading Company Strategies by Buyers - Global Pharmaceutical Industry (%),2013Figure 10: Change in Leading Company Strategies by Suppliers - Global Pharmaceutical Industry (%),2013Figure 11: Change in Leading Company Strategies by Region - Global Pharmaceutical Industry (%),2013Figure 12: Change in Leading Company Strategies by Turnover - Global Pharmaceutical Industry (%),2013Figure 13: MandA Activity Projections - Global Pharmaceutical Industry (%), 2013Figure 14: MandA Activity Projections - Global Pharmaceutical Manufacturers Industry (%), 2010-2013Figure 15: MandA Activity Projections - Global CROs and CMOs (%), 2010-2013Figure 16: MandA Activity Projections - Global Pharmaceutical Industry Suppliers (%), 2010-2013Figure 17: Global Pharmaceutical Industry MandA Activity Projections by Region (%), 2013
    • Figure 18: Global Pharmaceutical Industry MandA Activity Projections by Turnover (%), 2013Figure 19: Global Pharmaceutical Industry MandA Activity Projections by Purchasing DecisionAuthority (%), 2013Figure 20: Global Pharmaceutical Industry - Expand Abroad Vs MandA Activity Projections (%), 2013Figure 21: Change in Capital Expenditure by Global Pharmaceutical Industry Manufacturers(%), 2013Figure 22: Change in Capital Expenditure by Global CROs and CMOs (%), 2013Figure 23: Change in Capital Expenditure by Pharmaceutical Industry Suppliers (%), 2013Figure 24: Global Pharmaceutical Industry - Increase in Capital Expenditure by Turnover (%), 2013Figure 25: Global Pharmaceutical Industry Manufacturers - Planned Change in Staff Recruitment (%),2013Figure 26: Global Pharmaceutical Industry Suppliers - Planned Change in Staff Recruitment Activity(%), 2013Figure 27: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity by Region(%), 2013Figure 28: Global Pharmaceutical Industry - Planned Change in Staff Recruitment Activity byTurnover (%), 2013Figure 29: Global Pharmaceutical Industry: Top Ten Growth Regions (%), 2013Figure 30: Global Pharmaceutical Industry: Top Five Emerging Markets, 2013Figure 31: Global Pharmaceutical Industry Manufacturers - Demand in Emerging Markets (%), 2013Figure 32: Global Pharmaceutical Industry CROs and CMOs - Demand in Emerging Markets (%), 2013Figure 33: Global Pharmaceutical Industry Suppliers - Demand in Emerging Markets (%), 2013Figure 34: Global Pharmaceutical Industry - Demand in Emerging Markets by Region (%), 2013Figure 35: Global Pharmaceutical Industry - Demand in Emerging Markets by Turnover (%), 2013Figure 36: Global Pharmaceutical Industry - Top Five Developed Regions by Growth (%), 2013Figure 37: Global Pharmaceutical Manufacturers- Growth Projections in Developed Countries (%),2013Figure 38: Global Pharmaceutical CROs and CMOs- Growth Projections in Developed Countries (%),2013Figure 39: Global Pharmaceutical Industry Suppliers - Growth Projections in Developed Countries(%), 2013Figure 40: Global Pharmaceutical Industry - Increase in Growth Projections of Developed Countriesby Region (%), 2013Figure 41: Global Pharmaceutical Industry - Top Five Leading Business Concerns, 2013Figure 42: Global Pharmaceutical Industry - Leading Business Concerns (%), 2013Figure 43: Global Pharmaceutical Industry - Leading Business Concerns by Company Type (%), 2013Figure 44: Global Pharmaceutical Industry - Leading Business Concerns by Turnover (%), 2013-2014Figure 45: Global Pharmaceutical Industry - Securing Buyer Business: Buyer vs. Supplier Responses(%), 2013Figure 46: Actions to Secure Buyer Business, Global Pharmaceutical Industry Buyer Responses (%),2013Figure 47: Global Pharmaceutical Industry - Securing Buyer Business by Region (%), 2013Figure 48: Annual Procurement Budgets of Global Pharmaceutical Industry Manufacturers in US$ (%),2010-2013Figure 49: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by BuyerType (%), 2013Figure 50: Global Pharmaceutical Industry Buyers - Annual Procurement Budgets in US$ by Turnover(%), 2013Figure 51: Global Pharmaceutical Industry - Annual Procurement Budgets in US$ by Senior LevelRespondents (%), 2013
    • Figure 52: Change in Procurement Expenditure - Global Pharmaceutical Industry Buyers (%), 2010-2013Figure 53: Global Pharmaceutical Industry - Change in Procurement Expenditure by Buyer Type (%),2013Figure 54: Global Pharmaceutical Industry - Change in Procurement Expenditure by Region (%), 2013Figure 55: Global Pharmaceutical Industry - Change in Procurement Expenditure by Turnover (%),2013Figure 56: Future Change in Expenditure by Product and Service Category, Buyers , 2013Figure 57: Future Change in Expenditure by Product and Service Category, Pharmaceutical IndustryManufacturers (%), 2013Figure 58: Future Change in Expenditure by Product and Service Category, CROs and CMOs (%), 2013Figure 59: Increase in Expenditure by Product and Service Category - Buyers by Turnover (%), 2013Figure 60: Global Pharmaceutical Industry - Variations in Regional Supplier Prices (%), 2013Figure 61: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Company Type(%), 2013Figure 62: Global Pharmaceutical Industry - Variations in Regional Supplier Prices by Region (%),2013Figure 63: Critical Success Factors for Supplier Selection - Global Pharmaceutical Industry Buyers,2013Figure 64: E-Procurement - Level of Implementation in the Global Pharmaceutical Industry (%),2013Figure 65: E-Procurement in the Global Pharmaceutical Industry: by Buyer Type(%), 2013Figure 66: E-Procurement in the Global Pharmaceutical Industry by Region (%), 2013Figure 67: E-Procurement in the Global Pharmaceutical Industry: by Turnover (%), 2013